{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T05:56:15Z","timestamp":1789797375375,"version":"4.0.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100021055","name":"Apnimed, Inc.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021055","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CHEST"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.chest.2025.09.019","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T03:28:36Z","timestamp":1758857316000},"page":"527-537","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Acetazolamide Plus Atomoxetine for Obesity Hypoventilation Syndrome Treatment"],"prefix":"10.1016","volume":"169","author":[{"given":"Elisa","family":"Perger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Parati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Faini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Gell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Faverio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Luppi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Bertoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Brunani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Bigagli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Taranto-Montemurro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.chest.2025.09.019_bib1","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1513\/AnnalsATS.202006-683ED","article-title":"Overlooking obesity hypoventilation syndrome: the need for obesity hypoventilation syndrome staging and risk stratification","volume":"17","author":"Randerath","year":"2020","journal-title":"Ann Am Thorac Soc"},{"issue":"9","key":"10.1016\/j.chest.2025.09.019_bib2","doi-asserted-by":"crossref","first-page":"879","DOI":"10.5664\/jcsm.2986","article-title":"Diagnostic predictors of obesity-hypoventilation syndrome in patients suspected of having sleep disordered breathing","volume":"9","author":"Macavei","year":"2013","journal-title":"J Clin Sleep Med"},{"issue":"3","key":"10.1016\/j.chest.2025.09.019_bib3","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1164\/rccm.201008-1280CI","article-title":"Obesity hypoventilation syndrome: mechanisms and management","volume":"183","author":"Piper","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"151","key":"10.1016\/j.chest.2025.09.019_bib4","doi-asserted-by":"crossref","first-page":"180097","DOI":"10.1183\/16000617.0097-2018","article-title":"Obesity hypoventilation syndrome","volume":"28","author":"Masa","year":"2019","journal-title":"Eur Respir Rev"},{"issue":"3","key":"10.1016\/j.chest.2025.09.019_bib5","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1378\/chest.09-0615","article-title":"Determinants of hypercapnia in obese patients with obstructive sleep apnea: a systematic review and metaanalysis of cohort studies","volume":"136","author":"Kaw","year":"2009","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.chest.2025.09.019_bib6","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1465-9921-14-132","article-title":"Respiratory mechanics and ventilatory control in overlap syndrome and obesity hypoventilation","volume":"14","author":"Verbraecken","year":"2013","journal-title":"Respir Res"},{"key":"10.1016\/j.chest.2025.09.019_bib7","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.sleep.2021.03.024","article-title":"Diagnostic approach to sleep disordered-breathing among patients with grade III obesity","volume":"82","author":"Perger","year":"2021","journal-title":"Sleep Med"},{"issue":"2","key":"10.1016\/j.chest.2025.09.019_bib8","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1378\/chest.128.2.587","article-title":"Short-term and long-term effects of nasal intermittent positive pressure ventilation in patients with obesity-hypoventilation syndrome","volume":"128","author":"P\u00e9rez de Llano","year":"2005","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.chest.2025.09.019_bib9","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.5664\/jcsm.7332","article-title":"The association between adherence to positive airway pressure therapy and long-term outcomes in patients with obesity hypoventilation syndrome: a prospective observational study","volume":"14","author":"Bouloukaki","year":"2018","journal-title":"J Clin Sleep Med"},{"issue":"1","key":"10.1016\/j.chest.2025.09.019_bib10","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1378\/chest.14-3216","article-title":"Postoperative complications in patients with unrecognized obesity hypoventilation syndrome undergoing elective noncardiac surgery","volume":"149","author":"Kaw","year":"2016","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.chest.2025.09.019_bib11","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1513\/AnnalsATS.201907-554OC","article-title":"Weight loss interventions as treatment of obesity hypoventilation syndrome. a systematic review","volume":"17","author":"Kakazu","year":"2020","journal-title":"Ann Am Thorac Soc"},{"issue":"11","key":"10.1016\/j.chest.2025.09.019_bib12","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.4187\/respcare.10551442","article-title":"Hypercapnic respiratory failure in obesity-hypoventilation syndrome: CO2 response and acetazolamide treatment effects","volume":"55","author":"Raurich","year":"2010","journal-title":"Respir Care"},{"issue":"1","key":"10.1016\/j.chest.2025.09.019_bib13","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1152\/jappl.1993.74.1.230","article-title":"Effects of acute and chronic acetazolamide on resting ventilation and ventilatory responses in men","volume":"74","author":"Swenson","year":"1993","journal-title":"J Appl Physiol"},{"issue":"1","key":"10.1016\/j.chest.2025.09.019_bib14","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.chest.2021.08.080","article-title":"Reboxetine plus oxybutynin for OSA treatment: a 1-week, randomized, placebo-controlled, double-blind crossover trial","volume":"161","author":"Perger","year":"2022","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.chest.2025.09.019_bib15","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1164\/rccm.202306-1036OC","article-title":"The Combination of Aroxybutynin and Atomoxetine in the Treatment of Obstructive Sleep Apnea (MARIPOSA): a randomized controlled trial","volume":"208","author":"Schweitzer","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.chest.2025.09.019_bib16","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00959-2016","article-title":"Definition, discrimination, diagnosis and treatment of central breathing disturbances during sleep","volume":"49","author":"Randerath","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.chest.2025.09.019_bib17","first-page":"2012","article-title":"The AASM Manual for the Scoring of Sleep and Associated Events. Rules, Terminology and Technical Specifications","volume":"176","author":"Berry","year":"2012","journal-title":"American Academy of Sleep Medicine"},{"issue":"5","key":"10.1016\/j.chest.2025.09.019_bib18","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1378\/chest.14-0970","article-title":"International classification of sleep disorders-third edition: highlights and modifications","volume":"146","author":"Sateia","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.chest.2025.09.019_bib19","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1164\/rccm.201808-1493OC","article-title":"The combination of atomoxetine and oxybutynin greatly reduces obstructive sleep apnea severity. A randomized, placebo-controlled, double-blind crossover trial","volume":"199(10)","author":"Taranto-Montemurro","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.chest.2025.09.019_bib20","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/MCP.0000000000000818","article-title":"Upper airway muscles: influence on obstructive sleep apnoea pathophysiology and pharmacological and technical treatment options","volume":"27","author":"Perger","year":"2021","journal-title":"Curr Opin Pulm Med"},{"issue":"6","key":"10.1016\/j.chest.2025.09.019_bib21","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1016\/j.chest.2020.06.078","article-title":"Acetazolamide for OSA and central sleep apnea: a comprehensive systematic review and meta-analysis","volume":"158","author":"Schmickl","year":"2020","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.chest.2025.09.019_bib22","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1113\/jphysiol.2011.223925","article-title":"Acetazolamide improves loop gain but not the other physiological traits causing obstructive sleep apnoea","volume":"590","author":"Edwards","year":"2012","journal-title":"J Physiol"},{"issue":"11","key":"10.1016\/j.chest.2025.09.019_bib23","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.5665\/sleep.2204","article-title":"A randomized, double-blind, placebo-controlled study of an oral, extended-release formulation of phentermine\/topiramate for the treatment of obstructive sleep apnea in obese adults","volume":"35","author":"Winslow","year":"2012","journal-title":"Sleep"},{"issue":"1","key":"10.1016\/j.chest.2025.09.019_bib24","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1183\/09031936.00158413","article-title":"Zonisamide reduces obstructive sleep apnoea: a randomised placebo-controlled study","volume":"44","author":"Eskandari","year":"2014","journal-title":"Eur Respir J"},{"issue":"12","key":"10.1016\/j.chest.2025.09.019_bib25","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1164\/rccm.202109-2043OC","article-title":"A randomized controlled clinical trial exploring safety and tolerability of sulthiame in sleep apnea","volume":"205","author":"Hedner","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.chest.2025.09.019_bib26","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/thorax-2023-220184","article-title":"Combination pharmacological therapy targeting multiple mechanisms of sleep apnoea: a randomised controlled cross-over trial","volume":"79","author":"Sands","year":"2024","journal-title":"Thorax"},{"key":"10.1016\/j.chest.2025.09.019_bib27","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.pupt.2017.03.002","article-title":"Effects of early administration of acetazolamide on the duration of mechanical ventilation in patients with chronic obstructive pulmonary disease or obesity-hypoventilation syndrome with metabolic alkalosis. A randomized trial","volume":"44","author":"Rialp Cervera","year":"2017","journal-title":"Pulm Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.chest.2025.09.019_bib28","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1165\/rcmb.2012-0487OC","article-title":"Hypercapnia impairs lung neutrophil function and increases mortality in murine pseudomonas pneumonia","volume":"49","author":"Gates","year":"2013","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.chest.2025.09.019_bib29","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2147\/OAEM.S242075","article-title":"Hypercapnia at hospital admission as a predictor of mortality","volume":"12","author":"Vonderbank","year":"2020","journal-title":"Open Access Emerg Med"},{"issue":"1","key":"10.1016\/j.chest.2025.09.019_bib30","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1465-9921-15-30","article-title":"Hypo- and hypercapnia predict mortality in oxygen-dependent chronic obstructive pulmonary disease: a population-based prospective study","volume":"15","author":"Ahmadi","year":"2014","journal-title":"Respir Res"},{"issue":"suppl 67","key":"10.1016\/j.chest.2025.09.019_bib31","article-title":"Normalized hypercapnia is a strong predictor of survival in patients with home mechanical ventilation (HMV)\u2014the population-based DISCOVERY study","volume":"62","author":"Palm","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.chest.2025.09.019_bib32","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1164\/rccm.201905-1071ST","article-title":"Evaluation and management of obesity hypoventilation syndrome. An official American Thoracic Society clinical practice guideline","volume":"200(3)","author":"Mokhlesi","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.chest.2025.09.019_bib33","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2020-000557","article-title":"Side effects of acetazolamide: a systematic review and meta-analysis assessing overall risk and dose dependence","volume":"7","author":"Schmickl","year":"2020","journal-title":"BMJ Open Respir Res"},{"issue":"2","key":"10.1016\/j.chest.2025.09.019_bib34","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3390\/metabo8020025","article-title":"Carbonic anhydrases and metabolism","volume":"8","author":"Supuran","year":"2018","journal-title":"Metabolites"},{"key":"10.1016\/j.chest.2025.09.019_bib35","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1080\/14756366.2022.2121393","article-title":"Anti-obesity carbonic anhydrase inhibitors: challenges and opportunities","volume":"37(1)","author":"Supuran","year":"2022","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"11","key":"10.1016\/j.chest.2025.09.019_bib36","doi-asserted-by":"crossref","DOI":"10.1093\/omcr\/omy081","article-title":"Acetazolamide promotes decreased consumption of carbonated drinks and weight loss","volume":"2018","author":"Mu\u00f1oz","year":"2018","journal-title":"Oxf Med Case Reports"},{"issue":"6","key":"10.1016\/j.chest.2025.09.019_bib37","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/MJT.0b013e31813e65b7","article-title":"Is acetazolamide similar to topiramate for reversal of antipsychotic-induced weight gain?","volume":"14","author":"Schneiderhan","year":"2007","journal-title":"Am J Ther"},{"issue":"5","key":"10.1016\/j.chest.2025.09.019_bib38","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1183\/09031936.00063008","article-title":"Inspiratory duty cycle responses to flow limitation predict nocturnal hypoventilation","volume":"33","author":"Schneider","year":"2009","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.chest.2025.09.019_bib40","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jsmc.2014.05.007","article-title":"Obesity hypoventilation syndrome epidemiology and diagnosis","volume":"9","author":"Balachandran","year":"2014","journal-title":"Sleep Med Clin"}],"container-title":["CHEST"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001236922505384X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001236922505384X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:42:32Z","timestamp":1776732152000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001236922505384X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S001236922505384X"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2025.09.019","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acetazolamide Plus Atomoxetine for Obesity Hypoventilation Syndrome Treatment","name":"articletitle","label":"Article Title"},{"value":"CHEST","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2025.09.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc under license from the American College of Chest Physicians.","name":"copyright","label":"Copyright"}]}}